Clinical Trial Update: Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing conventional doxorubicin with pegylated liposomal doxorubicin as neoadjuvant chemotherapy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antineoplastic-related Conditions

Drugs mentioned

• Doxorubicin (doxorubicin)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: Jilin University | Conditions: Antineoplastic Combined Chemotherapy Protocols | Phase 2 | Status: UNKNOWN